Menu
*By clicking the Submit button, I consent to being contacted by Altman-Nussbaum-Shunnarah Personal Injury Attorneys at the number I provided. I also consent to receiving advertisements and telemarketing messages by text message or pre-recorded call, either of which may be dialed by an autodialer. I acknowledge that my consent is not required for purchase, that standard message and data rates apply, and that clicking Submit constitutes my electronic signature for my consent to being contacted and my agreement to the Terms and Conditions.
AndroGel and other “low-T” treatments, which are available as testosterone gels, patches, pellets, and injections, have recently been linked to an increased risk of cardiac problems in older and middle-aged men with a history of heart disease. At Altman-Nussbaum-Shunnarah Personal Injury Attorneys, our attorneys believe that the manufacturers of AndroGel and other testosterone therapies had a duty to warn patients about the risk of heart attack and stroke, but failed to provide any indication of these potential side effects on their products’ labeling or advertising materials.
If you or a loved one suffered a heart attack, stroke, pulmonary embolism, or other serious side effect while on testosterone therapy, our attorneys may be able to help you file a lawsuit seeking compensation for medical bills, pain and suffering and other damages. To learn more about filing a lawsuit, contact us today for a free consultation.
In March 2015, the FDA announced that all testosterone replacement therapies must have their labels updated after the agency reviewed several studies that suggested men using the “low T” therapies are at an increased risk for heart attacks and strokes. In a drug safety communication, the agency said that the treatments have been overprescribed to men suffering from low testosterone due to aging, rather than a related medical issue. Therefore, the FDA said that the makers of these drugs must update their labels to include these risks and clarify the only approved use for the prescriptions. Furthermore, the FDA warned doctors to only prescribe these treatments to men who have had medical tests performed verifying that their low testosterone levels are the result of hypogonadism or another medical issue.
By filing a lawsuit, patients who were injured while using AndroGel or other testosterone therapies may be able to recover compensation for economic and non-economic losses. This may include compensation for pain and suffering, medical expenses, and lost income. Furthermore, taking legal action can help hold manufacturers accountable for releasing dangerous and defective products into the marketplace. Our attorneys are currently investigating potential lawsuits on behalf of men who used AndroGel or other testosterone therapies and suffered any of the following:
While some consumers are calling for class action lawsuits over testosterone therapies, our attorneys are investigating individual lawsuits on behalf of men who suffered heart attacks, strokes and other serious side effects while using the “low-T” products.
Altman-Nussbaum-Shunnarah Trial Attorneys is known nationwide for providing outstanding legal advice and excellent representation. We have recovered over $750 million in lawsuits involving 18 wheeler trucking litigation, wrongful death litigation, commercial vehicle litigation, motorcycle litigation, catastrophic litigation, and mass torts involving medical devices and bad drug litigation. Our prowess in the legal arena comes from our combined years of trial and complex litigation experience.
We founded our practice on the belief that the 7th amendment and the civil jury system is the best means to provide compensation to injured parties and deter wrongdoers from injuring others in the future.
Learn More Through
Our Social Media
Call mE
Alabama Athens Atlanta Bedford Birmingham Boston Buffalo Dallas Gulfport Georgia Houston Huntsville Little Rock Memphis Milwaukee Mobile Montgomery Nashville New Orleans Panama Pensacola Prattville Selma Tallahassee Indiana Washington DC
Altman-Nussbaum-Shunnarah © 2025
Privacy Policy Terms of Service Giveaway Terms and Conditions
Notifications
